Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion-Defined Rhabdomyosarcoma. - Bergsma P; Porazinski S; Istadi A; Chacon-Fajardo D; Mahmood Y; Lombardi S; Schuhmacher D; Barraclough-Franks H; Strbenac D; Dennis CV; Faizi-Sobbi P; Cahill E; et al. (Molecular cancer therapeutics, 2025)